Introduction
============

Rosai-Dorfman disease (RDD) is a benign histiocyte disorder that was originally described by Rosai and Dorfman in 1969 as sinus histiocytosis with massive lymphadenopathy. It mostly affects young adults. Patients typically present with a fever, leukocytosis, and non-painful cervical lymphadenopathy ([@b1-etm-0-0-8568],[@b2-etm-0-0-8568]). RDD sometimes involves extranodal organs, including the skin, soft tissue, and central nervous system ([@b1-etm-0-0-8568]). Bone involvement occurs in less than 10% of cases. Primary bone RDD, in the absence of lymphadenopathy, accounts for less than 1% of all cases ([@b2-etm-0-0-8568]). RDD is usually self-limiting disease, making systemic therapy rarely required ([@b3-etm-0-0-8568]). The imaging of osseous RDD typically shows a lytic lesion on radiography and CT. The differential diagnosis is broad and includes osteomyelitis, Langerhans cell histiocytosis, lymphoma, primary bone sarcoma and metastatic bone tumor ([@b4-etm-0-0-8568]). Therefore accurate diagnosis depends on histological examination.

We herein report a rare case of primary bone RDD that occurred in the pelvic bone of a two-year-old boy and we present a literature review of the management and clinical course of this type of disease.

Case report
===========

A two-year-old boy was admitted to our hospital due to limping of the right lower extremity, which persisted for two months without obvious pain. He had no perinatal medical problems. He had no history of the infection, such as upper respiratory tract infection or viral enteritis.

A physical examination showed slight limitation in the range of motion of his right hip joint without a leg length discrepancy. There was no swelling, redness, local heat, or percussion pain around his right hip joint. There was no cervical, axillary, popliteal, or inguinal lymphadenopathy. A laboratory examination revealed no abnormalities; his white blood cell count and hemoglobin and serum C-reactive protein (CRP) levels were normal. Tests for tumor markers, including AFP, CEA, CA19-9, CA125, NSE, HCG-β and sIL-2R, were negative.

Plain radiography showed an osteolytic lesion at the peri-acetabular region of his right ilium ([Fig. 1](#f1-etm-0-0-8568){ref-type="fig"}). Computed tomography (CT) showed a purely osteolytic lesion of the right ilium with slight discontinuity of the thin cortical bone and minor cortical fracture ([Fig. 2](#f2-etm-0-0-8568){ref-type="fig"}). New bone formation was not observed. Magnetic resonance imaging of the pelvis showed a peri-acetabular lesion at the ilium with an iso- to high heterogeneous signal intensity on T1-weighted imaging and a high heterogeneous signal intensity on T2-weighted imaging ([Fig. 3](#f3-etm-0-0-8568){ref-type="fig"}). Fluorodeoxyglucose positron emission tomography (FDG-PET) showed an abnormal accumulation in the right peri-acetabular lesion.

An incisional biopsy was performed to obtain a definite pathological diagnosis. Microscopy showed numerous large histiocytes interspersed with different amounts of lymphocytes, neutrophils, and plasma cells. Emperipolesis was observed in the cytoplasm of the large histiocytes. Immunohistochemistry was positive for CD68, CD163 and S-100 and negative for CD1a ([Fig. 4](#f4-etm-0-0-8568){ref-type="fig"}). The patient was diagnosed with primary RDD of bone in the ilium. Because the osteolytic lesion gradually diminished without any progression of clinical symptoms after the excisional biopsy, we carefully observed the patient without additional treatment. After 18 months of follow-up, the bone lesion on radiography and CT had disappeared completely, and no joint deformity was observed ([Fig. 5](#f5-etm-0-0-8568){ref-type="fig"}).

We are concerned about the risk of recurrence, growth failure, and osteoarthritis. We are planning to follow him until he reaches adulthood.

Discussion
==========

RDD is a rare histiocytic disorder initially described as a separate entity in 1969 by Rosai and Dorfman under the term sinus histiocytosis with massive lymphadenopathy ([@b1-etm-0-0-8568]). The majority of patients are adolescents and young adults, and the mean age at the onset is 20 years old. The analysis of a registry of 423 worldwide cases of RDD showed that the mean age of the onset was 20.6 years, with 58% of cases occurring in men and 42% in women ([@b2-etm-0-0-8568]).

The pathological findings of RDD are characterized by the proliferation of numerous large histiocytes containing abundant eosinophilic cytoplasm, enmeshed in a variably cellular, mixed inflammatory infiltration composed of plasma cells, lymphocytes, neutrophils, foamy macrophages and rare eosinophils. The characteristic feature of the large histiocytes in RDD is conspicuous emperipolesis-namely lymphocytophagocytosis-with intracytoplasmic lymphocytes, plasma cells, or neutrophils ([@b3-etm-0-0-8568],[@b5-etm-0-0-8568]). The histiocytes of RDD are immunoreactive for CD68, CD163 and S100 protein and lack reactivity for CD1a ([@b3-etm-0-0-8568]). This immunohistochemical feature of RDD differentiates it from LCH, in which the histiocytes are CD1a-positive and do not display emperipolesis. ECD can be differentially diagnosed from RDD based on the lack of emperipolesis, negative staining for S100 protein, and a characteristic imaging appearance that includes diaphyseal osteosclerosis of the long bone ([@b4-etm-0-0-8568]).

In the present case, microscopic findings showed emperipolesis within the histiocyte cytoplasm. Immunohistochemistry was positive for CD45, CD68, CD163, and lysozome and negative for CD1a. The patient had no clinical or laboratory evidence to support diagnoses of osteomyelitis, osteosarcoma, Ewing\'s sarcoma, or metastatic bone tumor, such as metastatic neuroblastoma or lymphoma. Thus, the diagnosis of primary bone RDD of the ilium was made.

Extranodal disease occurs in the upper respiratory tract, salivary glands, eyelids, and skin in approximately 28% of cases. Bone involvement in association with nodal disease is seen in \<10% of cases ([@b2-etm-0-0-8568]). Mosheimer *et al* ([@b6-etm-0-0-8568]) reviewed 108 RDD patients with bone involvement and reported that primary RDD of the bone was observed in 67 (74.4%) cases. Typical symptoms include pain and swelling, but bone lesions may be an incidental finding. Few reports have described the details of primary bone RDD ([@b4-etm-0-0-8568],[@b7-etm-0-0-8568]). The largest series describes 15 cases of primary intraosseous RDD ([@b31-etm-0-0-8568]).

The clinical information of 25 previously reported cases of primary bone RDD are summarized in [Table I](#tI-etm-0-0-8568){ref-type="table"}. Of the 25 patients, 9 patients were male (36%), and 16 were female (64%). The mean age was 28.7 (range: 1.5-60) years old. The two-year-old boy in the present case is the second youngest patient to have a solitary bone lesion without lymphadenopathy. Treatment in most patients consisted of curettage (n=12) or resection (n=8). One patient underwent curettage followed by radiotherapy. Four patients were managed conservatively, and their condition was classified as stable disease. One patient (n=9) received prednisone because his bone lesion was unresectable. Paryani reported a patient (n=21) who underwent radiotherapy for recurrent disease after curettage for the primary lesion. Overall, the clinical outcome of primary intraosseous RDD is good. Curettage and resection are effective for achieving local control.

In the present case, the osteolytic lesion of the RDD showed spontaneous remission without residual bone deformity after curettage of the lesion at the incisional biopsy. However, previous reports indicated various treatment strategies, including corticosteroids, chemotherapy, radiotherapy, surgical curettage, and resection. Among all RDD patients, 20% show spontaneous remission without therapy ([@b3-etm-0-0-8568]). Mosheimer *et al* ([@b6-etm-0-0-8568]) reported that additional nodal manifestations of osseous RDD led to a more systemic treatment approach. Mostly intensive treatment was related to disease manifestations of problematic organs, including the central nervous system, vessels, orbit, and nasal cavity. Demicco *et al* ([@b31-etm-0-0-8568]) reported the clinical course of RDD of bone. Of 12 patients that were available for follow-up, 5 eventually developed additional extraosseous manifestations, including testicular, lymph node, and subcutaneous lesions. One patient developed additional multiple lesions of bone without extraosseous disease. These additional lesions developed from three months to three years after initial treatment. Thus, at least three years of follow-up may be necessary to detect the development of additional lesions.

RDD arising from bone has been reported in the literature. However, primary bone RDD without lymphadenopathy is extremely rare. Furthermore, the majority of patients are adolescents and young adults, and the mean age at the onset is 20 years old. There was only one report describe a patient under five years old. Before the biopsy, we suspected Langerhans cell histiocytosis as the differential diagnosis. It is important to consider primary RDD of bone as a differential diagnosis when osteolytic lesions are observed, even if the patient is under five years old.
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![Plain radiography at first medical examination. Radiograph showing an osteolytic lesion of the right acetabulum (arrow). No significant periosteal reaction was observed.](etm-19-04-2983-g00){#f1-etm-0-0-8568}

![CT images of pelvis. (A) Axial CT image showing the purely osteolytic lesion of the right ilium (arrow). (B) Coronal CT image showing discontinuity of the thin cortical bone (arrow). New bone formation and periosteal reaction were not observed.](etm-19-04-2983-g01){#f2-etm-0-0-8568}

![MR images of pelvis. MR images showing the peri-acetabular lesion of the ilium with (A) iso- to high heterogeneous signal intensity on T1-weighted images and (B) high heterogeneous signal intensity on T2-weighted images.](etm-19-04-2983-g02){#f3-etm-0-0-8568}

![Microscopic findings. Large histiocytes demonstrated the emperipolesis of neutrophils, lymphocytes and plasma cells. Hematoxylin and eosin staining; (A) magnification, x100 and (B) magnification, x400. Emperipolesis was observed in the cytoplasm of the large histiocytes (arrow). Immunohistochemical findings revealed the positive staining for (C) CD68, (D) CD163 and (E) S-100. Magnification, x400.](etm-19-04-2983-g03){#f4-etm-0-0-8568}

![Plain radiograph after 18 months of follow-up. After 18 months of follow-up, plain radiography shows that the acetabular lytic lesion has disappeared.](etm-19-04-2983-g04){#f5-etm-0-0-8568}

###### 

Previous reports of primary bone Rosai-Dorfman disease.

  No.   Author, year                      Age, years   Sex   Site                                      Symptom                             Treatment                 Outcome (follow-up duration)                          (Refs.)
  ----- --------------------------------- ------------ ----- ----------------------------------------- ----------------------------------- ------------------------- ----------------------------------------------------- -----------------------
  1     Hamels *et al*, 1985              1.5          M     Radius                                    Pain, swelling                      Curettage                 NED (36 months)                                       ([@b7-etm-0-0-8568])
  2     Lewin *et al*, 1985               7            M     Metacarpal                                Pain for 1 year                     Amputation, RT            NED (24 months)                                       ([@b8-etm-0-0-8568])
  3     Nawroz and Wilson-Storey, 1989    11           M     Radius                                    Pain, swelling                      Curettage                 NED (48 months)                                       ([@b9-etm-0-0-8568])
  4     Allegranza *et al*, 1991          14           F     Parietemporal bone                        Pain                                Curettage                 NED (17 months)                                       ([@b10-etm-0-0-8568])
  5     Kademani *et al*, 2002            44           F     Maxilla                                   Pain, swelling                      Resection                 NED (14 months)                                       ([@b11-etm-0-0-8568])
  6     George *et al*, 2003              41           F     Radius                                    Pain                                Curettage                 NED (14 months)                                       ([@b12-etm-0-0-8568])
  7     Loh *et al*, 2004                 57           F     Triquetrum                                Pain for 1 year                     Curettage, RT             NED (12 months)                                       ([@b13-etm-0-0-8568])
  8     Mota Gamboa *et al*, 2004         19           F     Tibia                                     Swelling pain                       Resection                 NED (10 months)                                       ([@b14-etm-0-0-8568])
  9     Rodriguez-Galindo *et al*, 2004   9            F     Frontal bone                              Pain                                Curettage                 SD (12 months)                                        ([@b15-etm-0-0-8568])
  10    Al-Saad *et al*, 2005             17           M     T9 vertebra                               Pain                                Prednisolone              CR (7 weeks)                                          ([@b16-etm-0-0-8568])
  11    Miyake *et al*, 2005              38           F     Femur                                     Pain                                Observation               SD (6 months)                                         ([@b17-etm-0-0-8568])
  12    Sundaram *et al*, 2005            60           F     Femur, fibula                             Pathological fracture               Curettage                 Femoral lesion: NED, Fibular lesion: SD (30 months)   ([@b18-etm-0-0-8568])
  13    Tubbs *et al*, 2005               13           M     Mastoid bone                              Neck pain for 2 months              Mastoidectomy             Developed new cervical lesion (4 months)              ([@b19-etm-0-0-8568])
  14    Robert *et al*, 2006              23           F     Sacrum                                    Pain                                Embolization, resection   NED (12 months)                                       ([@b20-etm-0-0-8568])
  15    Keskin *et al*, 2007              29           F     Maxilla                                   Pain/swelling for 2 year            Resection                 NED (16 months)                                       ([@b21-etm-0-0-8568])
  16    Kang *et al*, 2011                25           F     Right talus                               Pain for 2 months                   Curettage                 NED (11 months)                                       ([@b22-etm-0-0-8568])
  17    Walczak *et al*, 2011             50           F     Right distal femur                        Pain for 7 months                   Curettage                 NED (22 months)                                       ([@b23-etm-0-0-8568])
  18    Hsu *et al*, 2011                 16           M     Right glenoid                             Pain for 1 week                     Observation               NED (9 months)                                        ([@b24-etm-0-0-8568])
  19    Tripathy *et al*, 2012            52           F     Carpal bone                               Pain for 2 years                    Observation               NED (9 months)                                        ([@b25-etm-0-0-8568])
  20    Dean *et al*, 2012                16           M     Distal radius, carpal Bones: Multifocal   Pain for 8 months                   Observation               SD (6 months)                                         ([@b26-etm-0-0-8568])
  21    Paryani *et al*, 2014             49           F     Right distal femur                        Pain                                Curettage, RT             Recurrence (1 year) and SD for 15 months after RT     ([@b27-etm-0-0-8568])
  22    Kim *et al*, 2014                 15           M     T6 and T12 vertebra body                  Back pain for 6 months              Resection                 NED (1 year))                                         ([@b28-etm-0-0-8568])
  23    Xu *et al*, 2015                  56           F     Right proximal tibia                      Progressive pain for 1 year         Curettage                 NED (4 years)                                         ([@b29-etm-0-0-8568])
  24    Hartenstine *et al*, 2016         38           F     Right 9th rib                             Back pain for 2 weeks               Excisional biopsy         NED (15 months)                                       ([@b30-etm-0-0-8568])
  25    Baker *et al*, 2017               19           M     Left distal femur                         Thigh pain lasting several months   Curettage                 NED (23 months)                                       ([@b4-etm-0-0-8568])

M, male; F, female; CR, complete remission; NED, no evidence of disease; SD, stable disease; RT, radiation therapy.
